Revenue

FCPT's latest acquisition seems minor, but it reveals a powerful strategy for navigating economic uncertainty by targeting essential, service-based real estate.

As hospitals face a ballooning $55B annual IT bill, Vizient's latest acquisition signals a major offensive to control costs beyond the traditional supply chain.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

Amid market uncertainty, Vornado's $1.1B valuation deal for Park Avenue Plaza signals a bullish long-term view on New York City's trophy office space.

With a $20M Series A led by L Catterton, Dr. Muneeb Shah's REMEDY is disrupting skincare. Here's how accessible science is winning over consumers.

Xeris Biopharma secures a new patent for its rare disease drug KEVEYIS until 2039, a strategic move to fend off generic competition and lock in revenue.

Chicago's Pure Lithium named a WEF Technology Pioneer, validating its disruptive lithium metal battery and a model that could upend global supply chains.

An $11.6M C-PACE deal is turning a vacant Dallas warehouse into a data center, revealing a key strategy for sustainable growth in the AI era.

Ottawa's new Safe Social Media Act imposes strict duties on tech giants to protect children, but raises critical questions about privacy and digital freedom.

Tokyo-based CTW, a leader in web-based anime games, is pitching to US microcap funds. What's the strategy behind this cross-border play for capital?

With a record-breaking IPO and over $1.2 billion raised this year, Parabilis Medicines is attacking diseases once thought untouchable. But can its Helicon platform deliver?

Ottawa’s new Safe Social Media Act is more than a child safety law; it's a high-stakes stress test for Big Tech's business models and a new front in the global war on digital risk.

Leveraged finance titans turned a personal fight into a philanthropic powerhouse, raising a record $4.3M to fund the science that’s turning the tide on melanoma.

As severe storms and tornadoes devastate Chicagoland, U-Haul activates its disaster relief program, offering free storage to thousands of affected residents.

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.

Hyperscale Data is deploying humanoid robots in its Michigan data center, a high-stakes bet to teach AI about the real world amid major financial pressures.

American Outdoor Brands faces a key test on June 25. With mixed results and a shifting market, can its innovation strategy deliver on investor hopes?

FINRA just made remote brokerage inspections permanent. Melissa Adams analyzes the sweeping changes and asks if this push for efficiency maintains investor safety.

As Ontario doctors adopt AI to fight burnout, a new training program from OntarioMD tackles the urgent medico-legal and privacy risks head-on.

The world's largest car carrier sets sail. Seaspan's Glovis Lighthouse uses LNG fuel to cut emissions and is ready for a zero-carbon future.